false
OasisLMS
Catalog
SCCM Resource Library
Con: Corticosteroids Should Be Used Only for Selec ...
Con: Corticosteroids Should Be Used Only for Selected Patients With ARDS or Severe Pneumonia
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discusses the nuanced decision-making process for administering steroids in patients with ARDS (Acute Respiratory Distress Syndrome). Although studies suggest an average benefit from steroids in clinical trials, individual patient responses can vary widely due to differences in baseline risk and pathophysiology. This is often referred to as the heterogeneity of treatment effect. The speaker advocates for a personalized approach, weighing the potential benefits and risks based on a patient's clinical characteristics, comorbidities, and acute presentation. Through examples of different patient cases, they illustrate a framework for categorizing patients into categories: those who should definitely receive steroids, those who should not, and those in a middle, more challenging category requiring case-by-case decision making. The speaker emphasizes the need for integrating this personalized approach into clinical workflows, potentially using sophisticated models and trials, to support effective treatment decisions in the future.
Asset Caption
One-Hour Concurrent Session | Pro/Con Debate: How I Use Corticosteroids for ARDS and Pneumonia
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
ARDS
steroids
personalized medicine
heterogeneity of treatment effect
clinical decision-making
×
Please select your language
1
English